Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - TOTAL EQUITY
Total Equity DMAC - DiaMedica Therapeutics Inc.
51.1 M
LAST VALUE
7.69%
2 YEAR CAGR
24.56%
5 YEAR CAGR
43.47%
10 YEAR CAGR